ClinicalTrials.Veeva

Menu
C

Centro Cardiovascular Salta | Salta, Argentina

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Empagliflozin
Finerenone
Bococizumab
BI 690517
Ziltivekimab
Milvexian
Vicadrostat
EMPagliflozin
LY3819469
PUFA

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

8 of 16 total trials

A Research Study Looking Into How Ziltivekimab Works Compared to Placebo in Participants With Heart Failure and Inflammation (ATHENA)

The study is being done to see if ziltivekimab can be used to treat participants living with heart failure and inflammation. Participants will either...

Enrolling
Systemic Inflammation
Heart Failure
Drug: Placebo
Drug: Ziltivekimab

The purpose of this study is to evaluate that milvexian is superior to placebo, in addition to standard-of-care, in reducing the risk of major advers...

Enrolling
Acute Coronary Syndrome
Drug: Milvexian
Other: Placebo

The purpose of this study is to evaluate if milvexian is at least as effective as apixaban for reducing the risk of the composite stroke and non-cent...

Active, not recruiting
Atrial Fibrillation
Drug: Apixaban Placebo
Drug: Milvexian

The purpose of this study is to evaluate the efficacy of lepodisiran in reducing cardiovascular risk in participants with high lipoprotein(a) who hav...

Enrolling
Atherosclerotic Cardiovascular Disease (ASCVD)
Elevated Lp(a)
Drug: Lepodisiran Sodium
Drug: Placebo

Researchers are looking for a better way to treat children and young adults who have heart failure with left ventricular systolic dysfunction (LVSD)....

Begins enrollment in 3 months
Heart Failure (Pediatric)
Left Ventricular Systolic Dysfunction
Drug: Finerenone (Kerendia, BAY94-8862)

Researchers are looking for a better way to treat children who have heart failure with left ventricular systolic dysfunction (LVSD). Heart failure is...

Begins enrollment this month
Left Ventricular Systolic Dysfunction
Heart Failure (Pediatric)
Drug: Placebo
Drug: Finerenone (Kerendia, BAY94-8862)

This study is open to adults with chronic heart failure (HF) who have a reduced left ventricular ejection fraction (LVEF) of less than 40%. People ca...

Enrolling
Heart Failure
Drug: Placebo
Drug: empagliflozin

This study is open to adults aged 18 or above legal age with heart failure. People can join the study if they have heart failure symptoms and a left...

Enrolling
Heart Failure
Drug: vicadrostat
Drug: Placebo

Trial sponsors

Boehringer Ingelheim logo
Lilly logo
Bayer logo
Janssen (J&J Innovative Medicine) logo
Pfizer logo
Novo Nordisk logo
F

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems